POINT BIOPHARMA GLOBAL INC's ticker is PNT and the CUSIP is 730541109. A total of 117 filers reported holding POINT BIOPHARMA GLOBAL INC in Q1 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $184,000 | +22.7% | 27,621 | +67.8% | 0.00% | – |
| Q2 2023 | $150,000 | +74.4% | 16,458 | +38.3% | 0.00% | – |
| Q1 2023 | $86,000 | -56.1% | 11,904 | -55.9% | 0.00% | – |
| Q4 2022 | $196,000 | -89.7% | 26,967 | -89.1% | 0.00% | -100.0% |
| Q3 2022 | $1,910,000 | +13.8% | 247,102 | +0.2% | 0.00% | – |
| Q2 2022 | $1,679,000 | -61.7% | 246,588 | -55.1% | 0.00% | -100.0% |
| Q1 2022 | $4,379,000 | +18939.1% | 549,459 | +13291.6% | 0.00% | – |
| Q4 2021 | $23,000 | 0.0% | 4,103 | +36.8% | 0.00% | – |
| Q3 2021 | $23,000 | – | 3,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 2,312,523 | $18,431,000 | 4.36% |
| GREAT POINT PARTNERS LLC | 2,060,000 | $16,418,000 | 3.97% |
| RA Capital Management | 9,003,018 | $71,754,000 | 1.57% |
| JOHNSON & JOHNSON | 1,000,000 | $7,970,000 | 1.51% |
| BVF INC/IL | 3,367,826 | $26,842,000 | 1.07% |
| Boxer Capital, LLC | 2,500,000 | $19,925,000 | 1.02% |
| Sio Capital Management, LLC | 377,684 | $3,010,000 | 1.00% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,014,408 | $24,025,000 | 0.73% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 204,679 | $1,631,000 | 0.68% |
| Atom Investors LP | 60,103 | $479,000 | 0.22% |